Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Optimizerx | Mind Blowing Facts

OptimizeRx Q1 Earnings Call Highlights

OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life sciences customers and shorter contract commitments tied in part to most-favored-nation pricing dynamics

OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push

OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push

Following the release of its second-quarter financial results, OptimizerRx Corp (NASDAQ:OPRX) stock witnessed a 22.66% surge during after-hours trading on Thursday.

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022

OptimizeRx: Q4 Earnings Insights

OptimizeRx (NASDAQ:OPRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings OptimizeRx beat estimated earnings by 10.0%, reporting an EPS of $0.22 versus an estimate of $0.2.

1

People

195,719 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Delta Air Lines

Micron Technology

Paramount Global

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

385,025 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play